The elevated levels of IL-10 in the plasma of chronic hepatitis C (CHC) patients and their high degree of IL-10 reliance, both spontaneously and following HCV antigen stimulation [122], highlight its potential as a therapeutic target. Here, IL10 is linked to chronic hepatitis C virus infection.